Close Kinetic Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome

NCT02241148 | Terminated

• 1 other identifier: OR14-003
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators will include patients attending outpatient clinic in the area of Orthopedics and Traumatology of our hospital with a diagnosis of unilateral Patellofemoral Pain Syndrome. Two groups would be made, the control group will receive treatment with acetaminophen and physical therapy rehabilitation, closed chain exercises and stretches at home intended for the strengthening of quadriceps, abductors and internal rotators of the hip for the duration of six weeks. The experimental treatment group will receive the above plus the application of the technique NUCAP Medical Upper Knee Spider ® Kinesio taping on the affected knee. Both groups will be evaluated by an external consultation. They will be assessed by the Tegner Activity Scale, the Kujala score of the WOMAC and visual analog scale (VAS) for pain assessment; these scales will be applied at the beginning, third and sixth week

Conditions

Patellofemoral Pain Syndrome

Outcome Measures

Primary Outcomes (1)

• Closed kinetic chain exercise with kinesio taping pain relief measured in the Kujala score

  The Kujala patellofemoral score is a functional evaluation instrument to evaluate knee problems related to the patellofemoral system.It is a 13-item knee-specific self-report questionnaire. It documents response to six activities thought to be associated specifically with anterior knee pain syndrome (walking, running, jumping, climbing stairs, squatting, and sitting for prolonged periods with knees bent), as well as symptoms such as limp, inability to weight bear through the affected limb, swelling, abnormal patellar movement, muscle atrophy and limitation of knee flexion.

  Baseline,3 weeks, 6 weeks

Secondary Outcomes (1)

• Closed kinetic chain exercise with kinesio taping pain relief measured in the Tegner Activity Scale.

  Baseline, 3 weeks, 6 weeks

Other Outcomes (2)

• Closed kinetic chain exercise with kinesio taping pain relief measured in WOMAC

  Baseline, 3 weeks, 6 weeks

• Closed kinetic chain exercise with kinesio taping pain relief measured in the visual analog scale (VAS) for pain assessment.

  Baseline, 3 weeks, 6 weeks

Study Arms (2)

Acetaminophen 500mg

ACTIVE COMPARATOR

The control group will receive treatment with acetaminophen 500mg and physical therapy rehabilitation

Drug: Acetaminophen 500mg

Kinesio taping

EXPERIMENTAL

The experimental treatment group will receive acetaminophen 500mg and physical therapy rehabilitation, plus the application of the technique NUCAP Medical Upper Knee Spider ® Kinesio taping

Device: Kinesio taping

Interventions

Acetaminophen 500mg DRUG

500 mg, tablets every 8 hours

Also known as: Tempra® 500mg

Acetaminophen 500mg

Kinesio taping DEVICE

Taping will be changed every week.

Also known as: SpiderTech ® Kinesio taping

Kinesio taping

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Age between fifteen and thirty-five years,
• Presenting unilateral PFPS with six months of evolution,
• Presenting anterior or retro knee pain that presents itself when undergoing two or more of the following activities:
• (squatting, running,kneeling, jumping,climbing stairs,physically active patients, with at least thirty minutes of physical activity at least three times per week.)

You may not qualify if:

• Patients with previous knee surgeries,
• Chronic pain with more than one year of evolution,
• Pregnancy or suspected pregnancy
• Application of intra-articular steroids in the three months prior to their evaluation
• Patients with meniscal injuries
• Ligament or intra-articular knee structures
• Degenerative diseases such as diabetes
• Rheumatoid arthritis
• Osteoarthritis of the knee, hip or ankle
• History of dislocation or subluxation of patella
• Osgood Schlatter syndrome
• Patellar tendinitis or quadriceps.

Sponsors & Collaborators

• Universidad Autonoma de Nuevo Leon: lead

Study Sites (1)

Facultad de Medicina UANL

Monterrey, Nuevo León, 66235, Mexico

Location

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Acetanilides; Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines

Study Officials

• Felix Vilchez, Dr. med.

  Universidad Autonoma de Nuevo Leon

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr. med. Felix Vilchez Cavazos

Study Record Dates

• First Submitted: July 26, 2014
• First Posted: September 16, 2014
• Study Start: February 1, 2014
• Primary Completion: August 17, 2017
• Study Completion: August 17, 2017
• Last Updated: October 23, 2019

Record last verified: 2019-10

Locations

ME (1)